Status:
COMPLETED
Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil
Lead Sponsor:
Hawler Medical University
Collaborating Sponsors:
NEGATIVE
Conditions:
Missed Abortion
Eligibility:
FEMALE
19-35 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effectiveness of buccal misoprostol and comparing this with vaginal route of the same drug.
Eligibility Criteria
Inclusion
- first trimester missed abortion
Exclusion
- history or evidence of disorders that represent contraindication to the use of misoprostol:
- severe pulmonary diseases
- congenital or acquired heart diseases
- glaucoma
- prolonged use of corticosteroid
- sickle cell anemia and adrenal insufficiency
- smokers
- known hypersensitivity to drugs
- any evidence of infection
- patient's refusal to participate in the study
- patients with abnormal results of investigations
- patients with previous operations on cervix like conisation, cauterization, previous dilatation and curettage
- patients with complete abortion
- patients with severe bleeding that required emergency surgical evacuation of the uterus
- patients with partially dissolved tablets at the site of application in both groups
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00892229
Start Date
March 1 2007
End Date
March 1 2008
Last Update
May 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iraqi Medical Specialization
Risafa, Baghdad Governorate, Iraq, 00964